{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:06:48Z","timestamp":1759334808482,"version":"build-2065373602"},"reference-count":67,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.jaad.2014.12.002","type":"journal-article","created":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T23:45:27Z","timestamp":1420847127000},"page":"696-702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Viral infections in acute graft-versus-host disease: A review of diagnostic and therapeutic approaches"],"prefix":"10.1016","volume":"72","author":[{"given":"Lana X.","family":"Tong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D.","family":"Worswick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2014.12.002_bib1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.beha.2008.02.017","article-title":"Infectious complications of acute and chronic GVHD","volume":"21","author":"Young","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.jaad.2014.12.002_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2011.11.961","article-title":"Graft-versus-host disease: part I. Pathogenesis and clinical manifestations of graft-versus-host disease","volume":"66","author":"Hymes","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.12.002_bib3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1399-3046.2010.01325.x","article-title":"Cytomegalovirus, adenovirus, and polyomavirus co-infection among pediatric recipients of allogeneic stem cell transplantation: characteristics and outcome","volume":"14","author":"Watcharananan","year":"2010","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jaad.2014.12.002_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/bmt.2010.52","article-title":"Observational prospective study of viral infections in children undergoing allogeneic hematopoietic cell transplantation: a 3-year GETMON experience","volume":"46","author":"Verdeguer","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaad.2014.12.002_bib5","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbmt.2007.06.006","article-title":"Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources","volume":"13","author":"Walker","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"suppl 4","key":"10.1016\/j.jaad.2014.12.002_bib6","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1111\/j.1600-6143.2009.02897.x","article-title":"AST Infectious Diseases Community of Practice. Cytomegalovirus in solid organ transplant recipients","volume":"9","author":"Humar","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jaad.2014.12.002_bib7","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1473-3099(04)01202-2","article-title":"Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments","volume":"4","author":"Gandhi","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jaad.2014.12.002_bib8","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/1471-2334-13-310","article-title":"Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Dieamant","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jaad.2014.12.002_bib9","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.bbmt.2010.03.020","article-title":"Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease","volume":"16","author":"Cantoni","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaad.2014.12.002_bib10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1083-8791(00)70010-3","article-title":"CMV antigenemia following bone marrow transplantation: risk factors and outcomes","volume":"6","author":"Osarogiagbon","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaad.2014.12.002_bib11","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood.V88.10.4063.bloodjournal88104063","article-title":"Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study","volume":"88","author":"Boeckh","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2014.12.002_bib12","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1182\/blood-2007-11-121558","article-title":"Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study","volume":"111","author":"Winston","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2014.12.002_bib13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/0003-4819-109-10-777","article-title":"Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin","volume":"109","author":"Emanuel","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2014.12.002_bib14","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-154-5-201103010-01003","article-title":"Herpes zoster","volume":"154","author":"Wilson","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2014.12.002_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1083-8791(00)70051-6","article-title":"Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome","volume":"6","author":"Koc","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaad.2014.12.002_bib16","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2005-09-3624","article-title":"Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation\u2014a randomized double-blind placebo-controlled study","volume":"107","author":"Boeckh","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2014.12.002_bib17","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood-2007-03-077644","article-title":"One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation","volume":"110","author":"Erard","year":"2007","journal-title":"Blood"},{"issue":"6 suppl","key":"10.1016\/j.jaad.2014.12.002_bib18","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1016\/j.jaad.2007.09.016","article-title":"Management of herpes zoster and postherpetic neuralgia","volume":"57","author":"Tyring","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.12.002_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2006.12.011","article-title":"Diagnostic evaluation of mononucleosis-like illnesses","volume":"120","author":"Hurt","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2014.12.002_bib20","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2141.2005.05875.x","article-title":"The presence of IFNG 3\/3 genotype in the recipient associates with increased risk for Epstein\u2013Barr virus reactivation after allogeneic haematopoietic stem cell transplantation","volume":"132","author":"Bogunia-Kubik","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaad.2014.12.002_bib21","first-page":"383","article-title":"Monitoring of early Epstein\u2013Barr virus reactivation and preemptive therapy after allogeneic hematopoietic stem cell transplantation [in Chinese]","volume":"50","author":"Lu","year":"2011","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.jaad.2014.12.002_bib22","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1182\/blood.V91.8.3079.3079_3079_3083","article-title":"Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users","volume":"91","author":"Hale","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2014.12.002_bib23","first-page":"377","article-title":"Risk factors for developing EBV-related B cell lymphoproliferative disorders (BLPD) after non-HLA-identical BMT in children","volume":"18","author":"Gerritsen","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaad.2014.12.002_bib24","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1182\/blood-2008-09-178046","article-title":"Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2014.12.002_bib25","doi-asserted-by":"crossref","first-page":"E491","DOI":"10.1111\/ctr.12172","article-title":"Epstein\u2013Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation","volume":"27","author":"Zallio","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jaad.2014.12.002_bib26","first-page":"2208","article-title":"Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study","volume":"94","author":"Curtis","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2014.12.002_bib27","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1182\/blood.V99.12.4364","article-title":"Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation","volume":"99","author":"van Esser","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2014.12.002_bib28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1386-6532(03)00022-2","article-title":"Lymphoproliferative disease after allogeneic stem cell transplantation\u2014pre-emptive diagnosis by quantification of Epstein-Barr virus DNA in serum","volume":"28","author":"Aalto","year":"2003","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jaad.2014.12.002_bib29","first-page":"445","article-title":"The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience","volume":"33","author":"Kogan-Liberman","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaad.2014.12.002_bib30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/ejh.12260","article-title":"Controlled Epstein-Barr virus reactivation after allogeneic transplantation is associated with improved survival","volume":"92","author":"Auger","year":"2014","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jaad.2014.12.002_bib31","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1002\/hep.23533","article-title":"Hepatobiliary complications of hematopoietic cell transplantation, 40 years on","volume":"51","author":"McDonald","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jaad.2014.12.002_bib32","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1053\/jhep.2002.35068","article-title":"Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation","volume":"36","author":"Lau","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jaad.2014.12.002_bib33","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.3748\/wjg.v18.i16.1851","article-title":"Gastrointestinal and hepatic complications of hematopoietic stem cell transplantation","volume":"18","author":"Tuncer","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaad.2014.12.002_bib34","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2893.2006.00830.x","article-title":"Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor","volume":"14","author":"Knoll","year":"2007","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jaad.2014.12.002_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1053\/j.seminhematol.2011.10.006","article-title":"Gastrointestinal, hepatobiliary, pancreatic, and iron-related diseases in long-term survivors of allogeneic hematopoietic cell transplantation","volume":"49","author":"Kida","year":"2012","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jaad.2014.12.002_bib36","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/sj.bmt.1705290","article-title":"Adefovir therapy for lamivudine escape and hepatitis B virus reactivation after reduced intensity conditioning allogeneic stem cell transplantation","volume":"37","author":"Fouillard","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaad.2014.12.002_bib37","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.bbmt.2007.07.007","article-title":"Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor","volume":"13","author":"Robin","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaad.2014.12.002_bib38","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1517\/14656566.4.5.685","article-title":"Pegylated interferon with ribavirin therapy for chronic infection with the hepatitis C virus","volume":"4","author":"Foster","year":"2003","journal-title":"Exp Opin Pharmacother"},{"key":"10.1016\/j.jaad.2014.12.002_bib39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/120347540500900401","article-title":"Erythema infectiosum","volume":"9","author":"Vafaie","year":"2005","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2014.12.002_bib40","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.bmt.1705589","article-title":"Human parvovirus B19 infection with GvHD-like erythema in two allogeneic stem cell transplant recipients","volume":"39","author":"Muetherig","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaad.2014.12.002_bib41","first-page":"315","article-title":"Pure red cell aplasia induced by B19 parvovirus during allogeneic bone marrow transplantation","author":"Niitsu","year":"1989","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jaad.2014.12.002_bib42","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.autrev.2004.10.004","article-title":"Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia","volume":"4","author":"Mouthon","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2014.12.002_bib43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jcv.2008.08.008","article-title":"Human herpesvirus type 6 reactivation after haematopoietic stem cell transplantation","volume":"43","author":"de Pagter","year":"2008","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jaad.2014.12.002_bib44","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3201\/eid0503.990306","article-title":"Human herpesvirus 6: an emerging pathogen","volume":"5","author":"Campadelli-Fiume","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jaad.2014.12.002_bib45","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.med.51.1.423","article-title":"The spectrum of human herpesvirus 6 infection: from roseola infantum to adult disease","volume":"51","author":"Stoeckle","year":"2000","journal-title":"Ann Rev Med"},{"key":"10.1016\/j.jaad.2014.12.002_bib46","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1097\/TP.0b013e318289958b","article-title":"Human herpesvirus 6 infection after allogeneic stem cell transplantation: incidence, outcome, and factors associated with HHV-6 reactivation","volume":"95","author":"Jeulin","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2014.12.002_bib47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/sj.bmt.1702459","article-title":"Evaluation of CMV\/human herpes virus-6 positivity in bronchoalveolar lavage fluids as early detection of acute GVHD following BMT: evidence of a significant relationship","volume":"26","author":"Takemoto","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaad.2014.12.002_bib48","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1086\/428060","article-title":"Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation","volume":"40","author":"Zerr","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2014.12.002_bib49","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2141.2005.05788.x","article-title":"Infections with human herpesvirus 6 variant B delay platelet engraftment after allogeneic haematopoietic stem cell transplantation","volume":"131","author":"Radonic","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaad.2014.12.002_bib50","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1086\/498531","article-title":"Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance","volume":"193","author":"Ogata","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2014.12.002_bib51","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1086\/318142","article-title":"Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: a single-center prospective longitudinal study of 92 patients","volume":"31","author":"Imbert-Marcille","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2014.12.002_bib52","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2007-03-078881","article-title":"High T-cell response to human cytomegalovirus induces chemokine-mediated endothelial cell damage","volume":"110","author":"Bolovan-Fritts","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2014.12.002_bib53","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/bmt.2008.238","article-title":"Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation","volume":"42","author":"Wang","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaad.2014.12.002_bib54","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1084\/jem.167.5.1659","article-title":"In\u00a0vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6)","volume":"167","author":"Lusso","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2014.12.002_bib55","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jaad.2008.01.005","article-title":"Relationship among human herpesvirus 6 reactivation, serum interleukin 10 levels, and rash\/graft-versus-host disease after allogeneic stem cell transplantation","volume":"58","author":"Kitamura","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.12.002_bib56","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.7326\/0003-4819-124-12-199606150-00007","article-title":"Human herpesvirus-6 in transplantation: an emerging pathogen","volume":"124","author":"Singh","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2014.12.002_bib57","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/505498","article-title":"Adenovirus infections in transplant recipients","volume":"43","author":"Ison","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2014.12.002_bib58","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/0046-8177(91)90104-W","article-title":"Necrotizing tubulointerstitial nephritis associated with adenovirus infection","volume":"22","author":"Ito","year":"1991","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jaad.2014.12.002_bib59","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bbmt.2012.10.014","article-title":"Adenovirus viremia and disease: comparison of T cell-depleted and conventional hematopoietic stem cell transplantation recipients from a single institution","volume":"19","author":"Lee","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaad.2014.12.002_bib60","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1399-3062.2006.00184.x","article-title":"Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir","volume":"9","author":"Symeonidis","year":"2007","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jaad.2014.12.002_bib61","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/bmt.2010.86","article-title":"Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcome","volume":"46","author":"Ohrmalm","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaad.2014.12.002_bib62","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1399-3062.2010.00528.x","article-title":"Poor outcome of adenovirus infections in adult hematopoietic stem cell transplant patients with sustained adenovirus viremia","volume":"12","author":"Omar","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jaad.2014.12.002_bib63","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/bmt.2009.258","article-title":"Viral disease prevention after hematopoietic cell transplantation","volume":"44","author":"Zaia","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaad.2014.12.002_bib64","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jcv.2011.06.005","article-title":"High lethality of human adenovirus disease in adult allogeneic stem cell transplant recipients with high adenoviral blood load","volume":"52","author":"Ganzenmueller","year":"2011","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jaad.2014.12.002_bib65","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1086\/341770","article-title":"High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation","volume":"35","author":"Schilham","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2014.12.002_bib66","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1399-3062.2009.00391.x","article-title":"Safety and tolerability of cidofovir in high-risk pediatric patients","volume":"11","author":"Bhadri","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jaad.2014.12.002_bib67","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.bbmt.2011.09.007","article-title":"Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients","volume":"18","author":"Florescu","year":"2012","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214022208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214022208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:33:49Z","timestamp":1759271629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962214022208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":67,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0190962214022208"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2014.12.002","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Viral infections in acute graft-versus-host disease: A review of diagnostic and therapeutic approaches","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2014.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}